Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Carter Gould is an analyst at Barclays. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 03/19/2025
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 12/23/2024 | NBIX | Buy Now | Neurocrine Biosciences | $109.84 | 50.22% | Carter Gould58% | $160 → $165 | Maintains | Overweight | Get Alert |
| 11/07/2024 | GILD | Buy Now | Gilead Sciences | $107.01 | -11.22% | Carter Gould58% | $84 → $95 | Maintains | Equal-Weight | Get Alert |
| 11/01/2024 | REGN | Buy Now | Regeneron Pharmaceuticals | $663.01 | 60.63% | Carter Gould58% | $1080 → $1065 | Maintains | Overweight | Get Alert |
| 11/01/2024 | TVTX | Buy Now | Travere Therapeutics | $20.12 | -0.6% | Carter Gould58% | $18 → $20 | Maintains | Overweight | Get Alert |
| 10/31/2024 | LLY | Buy Now | Eli Lilly | $821.00 | 18.76% | Carter Gould58% | $1025 → $975 | Maintains | Overweight | Get Alert |
| 10/31/2024 | BIIB | Buy Now | Biogen | $143.09 | 25.79% | Carter Gould58% | $190 → $180 | Maintains | Equal-Weight | Get Alert |
| 10/23/2024 | REGN | Buy Now | Regeneron Pharmaceuticals | $663.01 | 62.89% | Carter Gould58% | $1220 → $1080 | Maintains | Overweight | Get Alert |
| 10/07/2024 | BMY | Buy Now | Bristol-Myers Squibb | $59.67 | -27.94% | Carter Gould58% | $42 → $43 | Maintains | Underweight | Get Alert |
| 10/07/2024 | MRK | Buy Now | Merck & Co | $94.90 | 47.52% | Carter Gould58% | $142 → $140 | Maintains | Overweight | Get Alert |
| 10/07/2024 | GILD | Buy Now | Gilead Sciences | $107.01 | -21.5% | Carter Gould58% | $76 → $84 | Maintains | Equal-Weight | Get Alert |
| 10/07/2024 | AMGN | Buy Now | Amgen | $319.93 | -1.54% | Carter Gould58% | $300 → $315 | Maintains | Equal-Weight | Get Alert |
| 10/07/2024 | ABBV | Buy Now | AbbVie | $214.59 | -1.21% | Carter Gould58% | $200 → $212 | Maintains | Overweight | Get Alert |
| 10/01/2024 | TVTX | Buy Now | Travere Therapeutics | $20.12 | -10.54% | Carter Gould58% | $14 → $18 | Maintains | Overweight | Get Alert |
| 09/09/2024 | NBIX | Buy Now | Neurocrine Biosciences | $109.84 | 45.67% | Carter Gould58% | $180 → $160 | Maintains | Overweight | Get Alert |
| 08/29/2024 | NUVL | Buy Now | Nuvalent | $76.66 | 30.45% | Carter Gould58% | → $100 | Initiates | → Overweight | Get Alert |
| 08/22/2024 | BMY | Buy Now | Bristol-Myers Squibb | $59.67 | -29.61% | Carter Gould58% | $41 → $42 | Maintains | Underweight | Get Alert |
| 08/14/2024 | VOR | Buy Now | Vor Biopharma | $0.88 | 240.91% | Carter Gould58% | $10 → $3 | Maintains | Overweight | Get Alert |
| 08/02/2024 | REGN | Buy Now | Regeneron Pharmaceuticals | $663.01 | 84.01% | Carter Gould58% | $1200 → $1220 | Maintains | Overweight | Get Alert |
| 08/02/2024 | NBIX | Buy Now | Neurocrine Biosciences | $109.84 | 63.87% | Carter Gould58% | $169 → $180 | Maintains | Overweight | Get Alert |
| 08/02/2024 | BIIB | Buy Now | Biogen | $143.09 | 32.78% | Carter Gould58% | $200 → $190 | Maintains | Equal-Weight | Get Alert |
| 08/02/2024 | TVTX | Buy Now | Travere Therapeutics | $20.12 | -30.42% | Carter Gould58% | $12 → $14 | Maintains | Overweight | Get Alert |
| 07/31/2024 | PFE | Buy Now | Pfizer | $26.33 | 21.53% | Carter Gould58% | $30 → $32 | Maintains | Equal-Weight | Get Alert |
| 07/31/2024 | MRK | Buy Now | Merck & Co | $94.90 | 49.63% | Carter Gould58% | $145 → $142 | Maintains | Overweight | Get Alert |
| 07/29/2024 | BMY | Buy Now | Bristol-Myers Squibb | $59.67 | -31.29% | Carter Gould58% | $41 → $41 | Downgrade | Equal-Weight → Underweight | Get Alert |
| 07/26/2024 | ABBV | Buy Now | AbbVie | $214.59 | -6.8% | Carter Gould58% | $187 → $200 | Maintains | Overweight | Get Alert |
| 07/10/2024 | BMY | Buy Now | Bristol-Myers Squibb | $59.67 | -31.29% | Carter Gould58% | $43 → $41 | Maintains | Equal-Weight | Get Alert |
| 07/10/2024 | LLY | Buy Now | Eli Lilly and Co | $821.00 | 24.85% | Carter Gould58% | $913 → $1025 | Maintains | Overweight | Get Alert |
| 07/10/2024 | PFE | Buy Now | Pfizer | $26.33 | 13.94% | Carter Gould58% | $28 → $30 | Maintains | Equal-Weight | Get Alert |
| 07/10/2024 | REGN | Buy Now | Regeneron Pharmaceuticals | $663.01 | 80.99% | Carter Gould58% | $1050 → $1200 | Maintains | Overweight | Get Alert |
| 06/13/2024 | BRNS | Buy Now | Barinthus Biotherapeutics | $1.02 | 194.12% | Carter Gould58% | $7 → $3 | Maintains | Overweight | Get Alert |
| 06/11/2024 | GERN | Buy Now | Geron | $1.71 | 426.32% | Carter Gould58% | → $9 | Initiates | → Overweight | Get Alert |
| 05/23/2024 | CYTK | Buy Now | Cytokinetics | $43.15 | 120.16% | Carter Gould58% | $100 → $95 | Maintains | Overweight | Get Alert |
| 05/03/2024 | AMGN | Buy Now | Amgen | $319.93 | -6.23% | Carter Gould58% | $230 → $300 | Upgrade | Underweight → Equal-Weight | Get Alert |
| 05/02/2024 | NBIX | Buy Now | Neurocrine Biosciences | $109.84 | 53.86% | Carter Gould58% | $150 → $169 | Maintains | Overweight | Get Alert |
| 04/29/2024 | GILD | Buy Now | Gilead Sciences | $107.01 | -28.98% | Carter Gould58% | $80 → $76 | Maintains | Equal-Weight | Get Alert |
| 04/29/2024 | ABBV | Buy Now | AbbVie | $214.59 | -12.86% | Carter Gould58% | $195 → $187 | Maintains | Overweight | Get Alert |
| 04/26/2024 | BMY | Buy Now | Bristol-Myers Squibb | $59.67 | -27.94% | Carter Gould58% | $51 → $43 | Maintains | Equal-Weight | Get Alert |
| 04/25/2024 | BIIB | Buy Now | Biogen | $143.09 | 39.77% | Carter Gould58% | $215 → $200 | Maintains | Equal-Weight | Get Alert |
| 04/16/2024 | SKIL | Buy Now | Skillsoft | $18.15 | 10.19% | Carter Gould58% | $25 → $20 | Maintains | Overweight | Get Alert |
| 04/04/2024 | BIIB | Buy Now | Biogen | $143.09 | 50.26% | Carter Gould58% | $230 → $215 | Maintains | Equal-Weight | Get Alert |
| 03/27/2024 | ABBV | Buy Now | AbbVie | $214.59 | -9.13% | Carter Gould58% | $185 → $195 | Maintains | Overweight | Get Alert |
| 02/29/2024 | ACLX | Buy Now | Arcellx | $69.87 | 4.48% | Carter Gould58% | $62 → $73 | Maintains | Overweight | Get Alert |
| 02/12/2024 | GILD | Buy Now | Gilead Sciences | $107.01 | -25.24% | Carter Gould58% | $85 → $80 | Maintains | Equal-Weight | Get Alert |
| 02/07/2024 | LLY | Buy Now | Eli Lilly | $821.00 | -1.34% | Carter Gould58% | $680 → $810 | Maintains | Overweight | Get Alert |
| 02/05/2024 | ABBV | Buy Now | AbbVie | $214.59 | -13.79% | Carter Gould58% | $175 → $185 | Maintains | Overweight | Get Alert |
| 02/02/2024 | MRK | Buy Now | Merck & Co | $94.90 | 52.79% | Carter Gould58% | $135 → $145 | Maintains | Overweight | Get Alert |
| 01/23/2024 | REGN | Buy Now | Regeneron Pharmaceuticals | $663.01 | 53.84% | Carter Gould58% | $935 → $1020 | Maintains | Overweight | Get Alert |
| 01/23/2024 | NBIX | Buy Now | Neurocrine Biosciences | $109.84 | 36.56% | Carter Gould58% | $145 → $150 | Maintains | Overweight | Get Alert |
| 01/23/2024 | MRK | Buy Now | Merck & Co | $94.90 | 42.26% | Carter Gould58% | $130 → $135 | Maintains | Overweight | Get Alert |
| 01/23/2024 | GILD | Buy Now | Gilead Sciences | $107.01 | -20.57% | Carter Gould58% | $82 → $85 | Maintains | Equal-Weight | Get Alert |
| 01/23/2024 | LLY | Buy Now | Eli Lilly | $821.00 | -17.17% | Carter Gould58% | $630 → $680 | Maintains | Overweight | Get Alert |
| 01/23/2024 | ABBV | Buy Now | AbbVie | $214.59 | -18.45% | Carter Gould58% | $170 → $175 | Maintains | Overweight | Get Alert |
| 01/17/2024 | ALLK | Buy Now | Allakos | $0.25 | 293.39% | Carter Gould58% | $1.5 → $1 | Maintains | Underweight | Get Alert |
| 12/14/2023 | PFE | Buy Now | Pfizer | $26.33 | 6.34% | Carter Gould58% | $34 → $28 | Maintains | Equal-Weight | Get Alert |
| 12/06/2023 | SKIL | Buy Now | Skillsoft | $18.15 | 65.29% | Carter Gould58% | $37 → $30 | Maintains | Overweight | Get Alert |
| 11/16/2023 | ACLX | Buy Now | Arcellx | $69.87 | -11.26% | Carter Gould58% | $49 → $62 | Maintains | Overweight | Get Alert |
| 11/14/2023 | ALLK | Buy Now | Allakos | $0.25 | 490.09% | Carter Gould58% | $2.5 → $1.5 | Maintains | Underweight | Get Alert |
| 11/01/2023 | PFE | Buy Now | Pfizer | $26.33 | 29.13% | Carter Gould58% | $35 → $34 | Maintains | Equal-Weight | Get Alert |
| 10/30/2023 | ABBV | Buy Now | AbbVie | $214.59 | -20.78% | Carter Gould58% | $160 → $170 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 10/27/2023 | BMY | Buy Now | Bristol-Myers Squibb | $59.67 | -14.53% | Carter Gould58% | $60 → $51 | Maintains | Equal-Weight | Get Alert |
| 09/22/2023 | TVTX | Buy Now | Travere Therapeutics | $20.12 | -40.36% | Carter Gould58% | $31 → $12 | Maintains | Overweight | Get Alert |
| 08/21/2023 | REGN | Buy Now | Regeneron Pharmaceuticals | $663.01 | 39.52% | Carter Gould58% | $900 → $925 | Maintains | Overweight | Get Alert |
| 08/18/2023 | SKIL | Buy Now | Skillsoft | $18.15 | -86.23% | Carter Gould58% | $58 → $50 | Maintains | Overweight | Get Alert |
| 08/09/2023 | LLY | Buy Now | Eli Lilly | $821.00 | -28.14% | Carter Gould58% | $500 → $590 | Maintains | Overweight | Get Alert |
| 08/08/2023 | BIIB | Buy Now | Biogen | $143.09 | 105.47% | Carter Gould58% | $311 → $294 | Maintains | Equal-Weight | Get Alert |
| 08/07/2023 | REGN | Buy Now | Regeneron Pharmaceuticals | $663.01 | 35.74% | Carter Gould58% | $888 → $900 | Maintains | Overweight | Get Alert |
| 08/01/2023 | RETA | Buy Now | Reata Pharmaceuticals | — | — | Carter Gould58% | $110 → $172 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 07/28/2023 | BMY | Buy Now | Bristol-Myers Squibb | $59.67 | 3.9% | Carter Gould58% | $64 → $62 | Maintains | Equal-Weight | Get Alert |
| 07/24/2023 | GILD | Buy Now | Gilead Sciences | $107.01 | -25.24% | Carter Gould58% | $81 → $80 | Maintains | Equal-Weight | Get Alert |
| 07/11/2023 | PFE | Buy Now | Pfizer | $26.33 | 44.32% | Carter Gould58% | $40 → $38 | Maintains | Equal-Weight | Get Alert |
| 07/11/2023 | GILD | Buy Now | Gilead Sciences | $107.01 | -24.31% | Carter Gould58% | $84 → $81 | Maintains | Equal-Weight | Get Alert |
| 07/11/2023 | BMY | Buy Now | Bristol-Myers Squibb | $59.67 | 7.26% | Carter Gould58% | $65 → $64 | Maintains | Equal-Weight | Get Alert |
| 07/11/2023 | AMGN | Buy Now | Amgen | $319.93 | -34.36% | Carter Gould58% | $225 → $210 | Maintains | Underweight | Get Alert |
| 06/28/2023 | REGN | Buy Now | Regeneron Pharmaceuticals | $663.01 | 33.93% | Carter Gould58% | $915 → $888 | Maintains | Overweight | Get Alert |
| 06/28/2023 | RETA | Buy Now | Reata Pharmaceuticals | — | — | Carter Gould58% | $98 → $110 | Maintains | Overweight | Get Alert |
| 06/08/2023 | BIIB | Buy Now | Biogen | $143.09 | — | Carter Gould58% | — | Maintains | Overweight | Get Alert |
| 06/07/2023 | SKIL | Buy Now | Skillsoft | $18.15 | -84.02% | Carter Gould58% | $70 → $58 | Maintains | Overweight | Get Alert |
| 05/11/2023 | RETA | Buy Now | Reata Pharmaceuticals | — | — | Carter Gould58% | $90 → $98 | Maintains | Overweight | Get Alert |
| 05/09/2023 | ACLX | Buy Now | Arcellx | $69.87 | -29.87% | Carter Gould58% | $38 → $49 | Maintains | Overweight | Get Alert |
| 05/05/2023 | ALEC | Buy Now | Alector | $1.32 | 809.09% | Carter Gould58% | $14 → $12 | Maintains | Overweight | Get Alert |
| 05/04/2023 | NBIX | Buy Now | Neurocrine Biosciences | $109.84 | 13.8% | Carter Gould58% | $131 → $125 | Maintains | Overweight | Get Alert |
| 05/03/2023 | PFE | Buy Now | Pfizer | $26.33 | 51.92% | Carter Gould58% | $43 → $40 | Maintains | Equal-Weight | Get Alert |
| 05/01/2023 | MRK | Buy Now | Merck & Co | $94.90 | 36.99% | Carter Gould58% | $128 → $130 | Maintains | Overweight | Get Alert |
| 05/01/2023 | LLY | Buy Now | Eli Lilly | $821.00 | -48.84% | Carter Gould58% | $400 → $420 | Maintains | Overweight | Get Alert |
| 05/01/2023 | BMY | Buy Now | Bristol-Myers Squibb | $59.67 | 8.93% | Carter Gould58% | $66 → $65 | Maintains | Equal-Weight | Get Alert |
| 05/01/2023 | AMGN | Buy Now | Amgen | $319.93 | -29.67% | Carter Gould58% | $227 → $225 | Maintains | Underweight | Get Alert |
| 04/26/2023 | BIIB | Buy Now | Biogen | $143.09 | 111.06% | Carter Gould58% | $307 → $302 | Maintains | Equal-Weight | Get Alert |
| 04/14/2023 | AMGN | Buy Now | Amgen | $319.93 | -29.05% | Carter Gould58% | $230 → $227 | Maintains | Underweight | Get Alert |
| 04/13/2023 | ABBV | Buy Now | AbbVie | $214.59 | -25.44% | Carter Gould58% | $155 → $160 | Maintains | Equal-Weight | Get Alert |
| 04/12/2023 | PFE | Buy Now | Pfizer | $26.33 | 63.31% | Carter Gould58% | $44 → $43 | Maintains | Equal-Weight | Get Alert |
| 04/12/2023 | SKIL | Buy Now | Skillsoft | $18.15 | -80.72% | Carter Gould58% | $80 → $70 | Maintains | Overweight | Get Alert |
| 03/24/2023 | REGN | Buy Now | Regeneron Pharmaceuticals | $663.01 | 38.01% | Carter Gould58% | $815 → $915 | Maintains | Overweight | Get Alert |
| 03/21/2023 | GOSS | Buy Now | Gossamer Bio | $1.43 | 5.18% | Carter Gould58% | $2 → $1.5 | Maintains | Equal-Weight | Get Alert |
| 03/01/2023 | RETA | Buy Now | Reata Pharmaceuticals | — | — | Carter Gould58% | $50 → $90 | Maintains | Overweight | Get Alert |
| 02/21/2023 | TVTX | Buy Now | Travere Therapeutics | $20.12 | 54.08% | Carter Gould58% | $37 → $31 | Maintains | Overweight | Get Alert |
| 02/07/2023 | NBIX | Buy Now | Neurocrine Biosciences | $109.84 | 19.26% | Carter Gould58% | $136 → $131 | Maintains | Overweight | Get Alert |
| 02/01/2023 | AMGN | Buy Now | Amgen | $319.93 | -28.11% | Carter Gould58% | $240 → $230 | Maintains | Underweight | Get Alert |
| 02/01/2023 | PFE | Buy Now | Pfizer | $26.33 | 67.11% | Carter Gould58% | $49 → $44 | Maintains | Equal-Weight | Get Alert |
| 01/18/2023 | GILD | Buy Now | Gilead Sciences | $107.01 | -21.5% | Carter Gould58% | $76 → $84 | Maintains | Equal-Weight | Get Alert |
| 01/18/2023 | AMGN | Buy Now | Amgen | $319.93 | -24.98% | Carter Gould58% | $234 → $240 | Maintains | Underweight | Get Alert |
| 01/03/2023 | LLY | Buy Now | Eli Lilly | $821.00 | -51.28% | Carter Gould58% | $395 → $400 | Maintains | Overweight | Get Alert |
| 12/12/2022 | ACLX | Buy Now | Arcellx | $69.87 | -45.61% | Carter Gould58% | $25 → $38 | Maintains | Overweight | Get Alert |
| 12/07/2022 | GOSS | Buy Now | Gossamer Bio | $1.43 | 40.24% | Carter Gould58% | $18 → $2 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 11/30/2022 | BIIB | Buy Now | Biogen | $143.09 | 118.74% | Carter Gould58% | $275 → $313 | Maintains | Equal-Weight | Get Alert |
| 11/11/2022 | VOR | Buy Now | Vor Biopharma | $0.88 | 1604.55% | Carter Gould58% | $26 → $15 | Maintains | Overweight | Get Alert |
| 11/11/2022 | MTEM | Buy Now | Molecular Templates | $0.00 | 999900% | Carter Gould58% | $67.5 → $15 | Maintains | Overweight | Get Alert |
| 11/09/2022 | RETA | Buy Now | Reata Pharmaceuticals | — | — | Carter Gould58% | $43 → $50 | Maintains | Overweight | Get Alert |
| 11/02/2022 | PFE | Buy Now | Pfizer | $26.33 | 86.1% | Carter Gould58% | $44 → $49 | Maintains | Equal-Weight | Get Alert |
| 11/02/2022 | LLY | Buy Now | Eli Lilly | $821.00 | -51.89% | Carter Gould58% | $355 → $395 | Maintains | Overweight | Get Alert |
| 10/31/2022 | ABBV | Buy Now | AbbVie | $214.59 | -27.77% | Carter Gould58% | $160 → $155 | Maintains | Equal-Weight | Get Alert |
| 10/31/2022 | GILD | Buy Now | Gilead Sciences | $107.01 | -28.98% | Carter Gould58% | $60 → $76 | Upgrade | Underweight → Equal-Weight | Get Alert |
| 10/31/2022 | AMGN | Buy Now | Amgen | $319.93 | -26.86% | Carter Gould58% | → $234 | Downgrade | Equal-Weight → Underweight | Get Alert |
| 10/28/2022 | MRK | Buy Now | Merck & Co | $94.90 | 15.91% | Carter Gould58% | $105 → $110 | Maintains | Overweight | Get Alert |
| 10/12/2022 | PFE | Buy Now | Pfizer | $26.33 | 67.11% | Carter Gould58% | $50 → $44 | Maintains | Equal-Weight | Get Alert |
| 10/12/2022 | GILD | Buy Now | Gilead Sciences | $107.01 | -43.93% | Carter Gould58% | $56 → $60 | Maintains | Underweight | Get Alert |
| 10/12/2022 | BMY | Buy Now | Bristol-Myers Squibb | $59.67 | 10.61% | Carter Gould58% | $69 → $66 | Maintains | Equal-Weight | Get Alert |
| 10/12/2022 | AMGN | Buy Now | Amgen | $319.93 | -26.86% | Carter Gould58% | $236 → $234 | Maintains | Equal-Weight | Get Alert |
| 10/07/2022 | BIIB | Buy Now | Biogen | $143.09 | 92.19% | Carter Gould58% | $200 → $275 | Maintains | Equal-Weight | Get Alert |
| 09/09/2022 | REGN | Buy Now | Regeneron Pharmaceuticals | $663.01 | 22.92% | Carter Gould58% | $735 → $815 | Maintains | Overweight | Get Alert |
| 08/18/2022 | GOSS | Buy Now | Gossamer Bio | $1.43 | 1162.18% | Carter Gould58% | $12 → $18 | Maintains | Overweight | Get Alert |
| 08/16/2022 | APLT | Buy Now | Applied Therapeutics | $0.52 | 329.39% | Carter Gould58% | $2.5 → $2.25 | Maintains | Equal-Weight | Get Alert |
| 08/05/2022 | NBIX | Buy Now | Neurocrine Biosciences | $109.84 | 2.88% | Carter Gould58% | $110 → $113 | Maintains | Overweight | Get Alert |
| 08/01/2022 | PFE | Buy Now | Pfizer | $26.33 | 97.49% | Carter Gould58% | $50 → $52 | Maintains | Equal-Weight | Get Alert |
| 08/01/2022 | ABBV | Buy Now | AbbVie | $214.59 | -25.44% | Carter Gould58% | $174 → $160 | Maintains | Equal-Weight | Get Alert |
| 07/29/2022 | MRK | Buy Now | Merck & Co | $94.90 | 6.43% | Carter Gould58% | $97 → $101 | Maintains | Overweight | Get Alert |
| 07/21/2022 | BIIB | Buy Now | Biogen | $143.09 | 39.77% | Carter Gould58% | $210 → $200 | Maintains | Equal-Weight | Get Alert |
| 05/11/2022 | ALLK | Buy Now | Allakos | $0.25 | 883.48% | Carter Gould58% | $7 → $2.5 | Maintains | Underweight | Get Alert |
| 05/11/2022 | ALEC | Buy Now | Alector | $1.32 | 960.61% | Carter Gould58% | $42 → $14 | Maintains | Overweight | Get Alert |
| 05/04/2022 | BIIB | Buy Now | Biogen | $143.09 | 46.76% | Carter Gould58% | $219 → $210 | Maintains | Equal-Weight | Get Alert |
| 05/02/2022 | BMY | Buy Now | Bristol-Myers Squibb | $59.67 | 13.96% | Carter Gould58% | $66 → $68 | Maintains | Equal-Weight | Get Alert |
| 04/26/2022 | GOSS | Buy Now | Gossamer Bio | $1.43 | 741.46% | Carter Gould58% | $18 → $12 | Maintains | Overweight | Get Alert |
| 04/12/2022 | REGN | Buy Now | Regeneron Pharmaceuticals | $663.01 | 12.37% | Carter Gould58% | $700 → $745 | Maintains | Overweight | Get Alert |
| 04/12/2022 | NBIX | Buy Now | Neurocrine Biosciences | $109.84 | 0.15% | Carter Gould58% | $100 → $110 | Maintains | Overweight | Get Alert |
| 04/12/2022 | MRK | Buy Now | Merck & Co | $94.90 | 2.21% | Carter Gould58% | $94 → $97 | Maintains | Overweight | Get Alert |
| 04/12/2022 | BIIB | Buy Now | Biogen | $143.09 | 53.05% | Carter Gould58% | $235 → $219 | Maintains | Equal-Weight | Get Alert |
| 04/12/2022 | AMGN | Buy Now | Amgen | $319.93 | -26.23% | Carter Gould58% | $233 → $236 | Maintains | Equal-Weight | Get Alert |
| 04/12/2022 | ABBV | Buy Now | AbbVie | $214.59 | -18.92% | Carter Gould58% | $150 → $174 | Maintains | Equal-Weight | Get Alert |
| 03/30/2022 | MTEM | Buy Now | Molecular Templates | $0.00 | 4499900% | Carter Gould58% | $120 → $67.5 | Maintains | Overweight | Get Alert |
| 03/21/2022 | VOR | Buy Now | Vor Biopharma | $0.88 | 2854.55% | Carter Gould58% | $56 → $26 | Maintains | Overweight | Get Alert |
| 03/21/2022 | APLT | Buy Now | Applied Therapeutics | $0.52 | 377.1% | Carter Gould58% | $7 → $2.5 | Maintains | Equal-Weight | Get Alert |
| 03/10/2022 | GILD | Buy Now | Gilead Sciences | $107.01 | -47.67% | Carter Gould58% | $63 → $56 | Maintains | Underweight | Get Alert |
| 02/09/2022 | AMGN | Buy Now | Amgen | $319.93 | -27.17% | Carter Gould58% | $228 → $233 | Maintains | Equal-Weight | Get Alert |
| 02/03/2022 | ABBV | Buy Now | AbbVie | $214.59 | -30.1% | Carter Gould58% | $133 → $150 | Maintains | Equal-Weight | Get Alert |
| 01/20/2022 | PAYC | Buy Now | Paycom Software | $214.88 | 76.84% | Carter Gould58% | $392 → $380 | Maintains | Equal-Weight | Get Alert |
| 01/20/2022 | NBIX | Buy Now | Neurocrine Biosciences | $109.84 | -8.96% | Carter Gould58% | $110 → $100 | Maintains | Overweight | Get Alert |
| 01/20/2022 | BIIB | Buy Now | Biogen | $143.09 | 70.52% | Carter Gould58% | $280 → $244 | Maintains | Equal-Weight | Get Alert |
| 01/20/2022 | ABBV | Buy Now | AbbVie | $214.59 | -38.02% | Carter Gould58% | $118 → $133 | Maintains | Equal-Weight | Get Alert |
| 01/04/2022 | APLT | Buy Now | Applied Therapeutics | $0.52 | 1235.88% | Carter Gould58% | $44 → $7 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 12/22/2021 | ALLK | Buy Now | Allakos | $0.25 | 3047.13% | Carter Gould58% | $36 → $8 | Maintains | Underweight | Get Alert |
| 12/20/2021 | LLY | Buy Now | Eli Lilly | $821.00 | -60.41% | Carter Gould58% | $280 → $325 | Maintains | Overweight | Get Alert |
| 12/16/2021 | TVTX | Buy Now | Travere Therapeutics | $20.12 | 98.81% | Carter Gould58% | $36 → $40 | Maintains | Overweight | Get Alert |
| 12/10/2021 | PFE | Buy Now | Pfizer | $26.33 | 105.09% | Carter Gould58% | $44 → $54 | Maintains | Equal-Weight | Get Alert |
| 12/09/2021 | RETA | Buy Now | Reata Pharmaceuticals | — | — | Carter Gould58% | $180 → $43 | Maintains | Overweight | Get Alert |
| 11/03/2021 | AMGN | Buy Now | Amgen | $319.93 | -28.73% | Carter Gould58% | $230 → $228 | Maintains | Equal-Weight | Get Alert |
| 11/01/2021 | MRK | Buy Now | Merck & Co | $94.90 | -0.95% | Carter Gould58% | $92 → $94 | Maintains | Overweight | Get Alert |
| 11/01/2021 | ABBV | Buy Now | AbbVie | $214.59 | -45.01% | Carter Gould58% | $112 → $118 | Maintains | Equal-Weight | Get Alert |
| 10/28/2021 | BMY | Buy Now | Bristol-Myers Squibb | $59.67 | 10.61% | Carter Gould58% | $68 → $66 | Maintains | Equal-Weight | Get Alert |
| 10/08/2021 | BMY | Buy Now | Bristol-Myers Squibb | $59.67 | 13.96% | Carter Gould58% | $71 → $68 | Maintains | Equal-Weight | Get Alert |
| 10/08/2021 | MRK | Buy Now | Merck & Co | $94.90 | -3.06% | Carter Gould58% | $87 → $92 | Maintains | Overweight | Get Alert |
| 10/08/2021 | BIIB | Buy Now | Biogen | $143.09 | 102.67% | Carter Gould58% | $395 → $290 | Maintains | Equal-Weight | Get Alert |
| 10/01/2021 | XLRN | Buy Now | Acceleron Pharma | — | — | Carter Gould58% | $150 → $180 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 08/06/2021 | REGN | Buy Now | Regeneron Pharmaceuticals | $663.01 | 6.33% | Carter Gould58% | $675 → $705 | Maintains | Overweight | Get Alert |
| 07/20/2021 | CYTK | Buy Now | Cytokinetics | $43.15 | -7.3% | Carter Gould58% | $28 → $40 | Maintains | Overweight | Get Alert |
| 07/06/2021 | LLY | Buy Now | Eli Lilly | $821.00 | -69.55% | Carter Gould58% | $227 → $250 | Maintains | Overweight | Get Alert |
| 06/08/2021 | BIIB | Buy Now | Biogen | $143.09 | 176.05% | Carter Gould58% | $265 → $395 | Maintains | Equal-Weight | Get Alert |
| 05/06/2021 | NBIX | Buy Now | Neurocrine Biosciences | $109.84 | 0.15% | Carter Gould58% | → $110 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 04/28/2021 | LLY | Buy Now | Eli Lilly | $821.00 | -72.35% | Carter Gould58% | $232 → $227 | Maintains | Overweight | Get Alert |
| 04/26/2021 | RETA | Buy Now | Reata Pharmaceuticals | — | — | Carter Gould58% | → $155 | Initiates | → Overweight | Get Alert |
| 03/05/2021 | AMGN | Buy Now | Amgen | $319.93 | -28.11% | Carter Gould58% | $242 → $230 | Maintains | Equal-Weight | Get Alert |
| 03/03/2021 | VOR | Buy Now | Vor Biopharma | $0.88 | 6263.64% | Carter Gould58% | → $56 | Initiates | → Overweight | Get Alert |
| 07/29/2020 | AMGN | Buy Now | Amgen | $319.93 | -21.86% | Carter Gould58% | $245 → $250 | Maintains | Equal-Weight | Get Alert |
| 07/29/2020 | ALEC | Buy Now | Alector | $1.32 | 2324.24% | Carter Gould58% | $36 → $32 | Maintains | Overweight | Get Alert |
| 06/22/2020 | BIIB | Buy Now | Biogen | $143.09 | 95.68% | Carter Gould58% | $370 → $280 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 05/07/2020 | NBIX | Buy Now | Neurocrine Biosciences | $109.84 | -1.68% | Carter Gould58% | $105 → $108 | Maintains | Equal-Weight | Get Alert |
| 04/29/2020 | PFE | Buy Now | Pfizer | $26.33 | 40.52% | Carter Gould58% | $36 → $37 | Maintains | Equal-Weight | Get Alert |
| 04/23/2020 | BIIB | Buy Now | Biogen | $143.09 | 158.58% | Carter Gould58% | $389 → $370 | Maintains | Overweight | Get Alert |
| 02/27/2020 | MTEM | Buy Now | Molecular Templates | $0.00 | 21999900% | Carter Gould58% | → $330 | Initiates | → Overweight | Get Alert |
| 02/27/2020 | GOSS | Buy Now | Gossamer Bio | $1.43 | 1372.55% | Carter Gould58% | → $21 | Initiates | → Overweight | Get Alert |
| 02/27/2020 | GILD | Buy Now | Gilead Sciences | $107.01 | -42.06% | Carter Gould58% | → $62 | Initiates | → Underweight | Get Alert |
| 02/27/2020 | APLT | Buy Now | Applied Therapeutics | $0.52 | 12113.74% | Carter Gould58% | → $64 | Initiates | → Overweight | Get Alert |
| 02/27/2020 | BMY | Buy Now | Bristol-Myers Squibb | $59.67 | 15.64% | Carter Gould58% | → $69 | Initiates | → Equal-Weight | Get Alert |
| 02/27/2020 | BIIB | Buy Now | Biogen | $143.09 | 171.86% | Carter Gould58% | → $389 | Initiates | → Overweight | Get Alert |
| 02/27/2020 | PFE | Buy Now | Pfizer | $26.33 | 36.73% | Carter Gould58% | → $36 | Initiates | → Equal-Weight | Get Alert |
| 02/27/2020 | XLRN | Buy Now | Acceleron Pharma | — | — | Carter Gould58% | → $107 | Initiates | → Overweight | Get Alert |
| 05/08/2019 | REGN | Buy Now | Regeneron Pharmaceuticals | $663.01 | -33.64% | Carter Gould58% | $480 → $440 | Maintains | Buy | Get Alert |
| 05/03/2019 | XLRN | Buy Now | Acceleron Pharma | — | — | Carter Gould58% | $54 → $45 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 04/10/2019 | GILD | Buy Now | Gilead Sciences | $107.01 | -28.04% | Carter Gould58% | $75 → $77 | Upgrade | Neutral → Buy | Get Alert |
| 04/01/2019 | CELG | Buy Now | Celgene | — | — | Carter Gould58% | — | Downgrade | Buy → Neutral | Get Alert |
| 03/22/2019 | BIIB | Buy Now | Biogen | $143.09 | — | Carter Gould58% | — | Downgrade | Buy → Neutral | Get Alert |
| 03/05/2019 | GOSS | Buy Now | Gossamer Bio | $1.43 | 1793.28% | Carter Gould58% | → $27 | Initiates | → Overweight | Get Alert |
| 03/04/2019 | ALEC | Buy Now | Alector | $1.32 | 1945.45% | Carter Gould58% | → $27 | Initiates | → Overweight | Get Alert |
| 01/16/2019 | INCY | Buy Now | Incyte | $60.00 | 36.67% | Carter Gould58% | $75 → $82 | Downgrade | Buy → Neutral | Get Alert |
| 07/26/2018 | VRTX | Buy Now | Vertex Pharmaceuticals | $512.23 | -63.3% | Carter Gould58% | $183 → $188 | Maintains | Neutral | Get Alert |
| 07/26/2018 | BIIB | Buy Now | Biogen | $143.09 | 176.05% | Carter Gould58% | $354 → $395 | Maintains | Buy | Get Alert |
| 04/12/2018 | INCY | Buy Now | Incyte | $60.00 | — | Carter Gould58% | — | Upgrade | Neutral → Buy | Get Alert |
| 01/31/2018 | BIIB | Buy Now | Biogen | $143.09 | — | Carter Gould58% | — | Upgrade | Neutral → Buy | Get Alert |
| 10/27/2017 | CELG | Buy Now | Celgene | — | — | Carter Gould58% | $146 → $120 | Maintains | Buy | Get Alert |
| 10/25/2017 | BIIB | Buy Now | Biogen | $143.09 | 122.24% | Carter Gould58% | $285 → $318 | Maintains | Neutral | Get Alert |
| 10/20/2017 | CELG | Buy Now | Celgene | — | — | Carter Gould58% | $153 → $146 | Maintains | Buy | Get Alert |
| 09/21/2017 | REGN | Buy Now | Regeneron Pharmaceuticals | $663.01 | -24.59% | Carter Gould58% | $535 → $500 | Maintains | Buy | Get Alert |
| 07/26/2017 | BIIB | Buy Now | Biogen | $143.09 | 99.18% | Carter Gould58% | $270 → $285 | Maintains | Neutral | Get Alert |
| 07/26/2017 | AMGN | Buy Now | Amgen | $319.93 | -42.17% | Carter Gould58% | $175 → $185 | Maintains | Neutral | Get Alert |
| 06/19/2017 | BIIB | Buy Now | Biogen | $143.09 | — | Carter Gould58% | — | Upgrade | Sell → Neutral | Get Alert |
| 03/09/2017 | XLRN | Buy Now | Acceleron Pharma | — | — | Carter Gould58% | → $36 | Initiates | → Buy | Get Alert |
| 03/09/2017 | GILD | Buy Now | Gilead Sciences | $107.01 | — | Carter Gould58% | — | Downgrade | Buy → Neutral | Get Alert |
| 03/09/2017 | AMGN | Buy Now | Amgen | $319.93 | -42.17% | Carter Gould58% | → $185 | Initiates | → Neutral | Get Alert |
| 03/09/2017 | INCY | Buy Now | Incyte | $60.00 | 133.33% | Carter Gould58% | → $140 | Initiates | → Neutral | Get Alert |
| 03/09/2017 | REGN | Buy Now | Regeneron Pharmaceuticals | $663.01 | -34.39% | Carter Gould58% | → $435 | Initiates | → Buy | Get Alert |
| 02/10/2016 | REGN | Buy Now | Regeneron Pharmaceuticals | $663.01 | -13.27% | Carter Gould58% | $645 → $575 | Maintains | Buy | Get Alert |
| 09/07/2015 | REGN | Buy Now | Regeneron Pharmaceuticals | $663.01 | — | Carter Gould58% | — | Upgrade | Sell → Buy | Get Alert |
| 07/15/2015 | CELG | Buy Now | Celgene | — | — | Carter Gould58% | $130 → $142 | Maintains | Buy | Get Alert |
| 07/09/2015 | REGN | Buy Now | Regeneron Pharmaceuticals | $663.01 | — | Carter Gould58% | — | Downgrade | Neutral → Sell | Get Alert |
| 05/07/2014 | REGN | Buy Now | Regeneron Pharmaceuticals | $663.01 | -51.74% | Carter Gould58% | $310 → $320 | Maintains | Neutral | Get Alert |
| 12/05/2013 | CELG | Buy Now | Celgene | — | — | Carter Gould58% | $81.5 → $100 | Upgrade | Neutral → Buy | Get Alert |
| 08/02/2013 | INCY | Buy Now | Incyte | $60.00 | -53.33% | Carter Gould58% | $27 → $28 | Maintains | Buy | Get Alert |
| 04/12/2013 | CELG | Buy Now | Celgene | — | — | Carter Gould58% | $50 → $63.5 | Maintains | Neutral | Get Alert |
| 09/10/2012 | CELG | Buy Now | Celgene | — | — | Carter Gould58% | $39 → $40 | Downgrade | Buy → Neutral | Get Alert |
| 04/27/2012 | INCY | Buy Now | Incyte Genomics | $60.00 | -56.67% | Carter Gould58% | $22 → $26 | Maintains | Buy | Get Alert |
| 04/27/2012 | CELG | Buy Now | Celgene | — | — | Carter Gould58% | $44 → $42.5 | Maintains | Buy | Get Alert |
